U.S. federal trademark · Serial No. 79410002 · Reg. No. 8105620
Diagnostic test kits comprised of medical diagnostic agents, preparations and substances for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects for medical purposes; chemical preparations intended for use in DNA analysis for medical use; reagents for use in medical genetic testing; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use
Biochemical preparations, namely, precursors intended for in vitro genetic engineering; diagnostic reagents for in vitro use for biochemistry, clinical chemistry and microbiology; chemical preparations for scientific purposes intended for use in DNA analysis, other than for medical use; enzymes, other than for medical use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for nonmedical purposes; reagents for nucleic acid amplification other than for medical or veterinary use
Laboratory apparatus for detecting genetic sequences; quantitative polymerase chain reaction (PCR) instrument for scientific use, namely, thermal cycler; laboratory apparatus and automatic machines for purifying nucleic acids, not for medical purposes
DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use; medical apparatus and automatic machines for purifying nucleic acids for medical use
Research with respect to DNA sequencing technology; research in the field of DNA analysis technology; scientific research in the field of genetics and genetic engineering; structural and functional analysis of genomes; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of health; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of biology; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of in vitro diagnostics; design, development and maintenance of software in the field of health; design, development and maintenance of software in the field of biology; design, development and maintenance of software in the field of in vitro diagnostics.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.